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A BS T R AC T
BACKGROUND

More than 30 million children worldwide have moderate acute malnutrition. Current treatments have limited effectiveness, and much remains unknown about the
pathogenesis of this condition. Children with moderate acute malnutrition have
perturbed development of their gut microbiota.
METHODS

In this study, we provided a microbiota-directed complementary food prototype
(MDCF-2) or a ready-to-use supplementary food (RUSF) to 123 slum-dwelling Bangladeshi children with moderate acute malnutrition between the ages of 12 months
and 18 months. The supplementation was given twice daily for 3 months, followed by 1 month of monitoring. We obtained weight-for-length, weight-for-age,
and length-for-age z scores and mid–upper-arm circumference values at baseline
and every 2 weeks during the intervention period and at 4 months. We compared the
rate of change of these related phenotypes between baseline and 3 months and
between baseline and 4 months. We also measured levels of 4977 proteins in
plasma and 209 bacterial taxa in fecal samples.
RESULTS

A total of 118 children (59 in each study group) completed the intervention. The
rates of change in the weight-for-length and weight-for-age z scores are consistent
with a benefit of MDCF-2 on growth over the course of the study, including the
1-month follow-up. Receipt of MDCF-2 was linked to the magnitude of change in
levels of 70 plasma proteins and of 21 associated bacterial taxa that were positively
correlated with the weight-for-length z score (P<0.001 for comparisons of both
protein and bacterial taxa). These proteins included mediators of bone growth and
neurodevelopment.
CONCLUSIONS

These findings provide support for MDCF-2 as a dietary supplement for young
children with moderate acute malnutrition and provide insight into mechanisms
by which this targeted manipulation of microbiota components may be linked to
growth. (Supported by the Bill and Melinda Gates Foundation and the National
Institutes of Health; ClinicalTrials.gov number, NCT04015999.)
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hildhood undernutrition is a
global health challenge that produces impaired ponderal and linear growth (wasting and stunting), immune and metabolic dysfunction, altered development of the central
nervous system (CNS), and other abnormalities.1,2
Acute malnutrition in children is classified by
the degree of wasting. Moderate acute malnutrition is defined as a weight-for-length measurement that is 2 or 3 SD below the median of the
cohort that was evaluated in the Multicenter
Growth Reference Study by the World Health
Organization; severe acute malnutrition is defined as a weight-for-length measurement that is
more than 3 SD below the median.3 Children
with these levels of malnutrition have defects in
the development of their gut microbiota, which
leaves them with microbial communities that
appear to be younger than those of their healthy
counterparts.4,5 Current nutritional interventions
for both moderate and severe forms of malnutrition have not focused on the microbiota as a
therapeutic target. Coincidentally, existing therapies have shown limited efficacy in treating the
long-term sequelae that affect undernourished
children6,7 and in repairing their microbiota.8
Since it has been estimated that the coronavirus
2019 pandemic will increase childhood mortality from wasting by more than 20%,9 surmounting this already formidable global health challenge has become even more pressing.
We previously identified a network (ecogroup)
of 15 bacterial taxa that can be used to describe
normal development of the gut microbial community during the first 2 years of postnatal life
in healthy members of birth cohorts in several
countries designated as low or middle income.5
Changes in the abundance of ecogroup taxa
provide a way of defining the severity of microbiota perturbations in children with untreated
moderate or severe malnutrition, as well as characterizing the incomplete nature of microbiota
repair that occurs when these children receive
existing therapeutic foods.5,8 Comparisons of
gnotobiotic mice that were colonized with fecal
microbiota obtained from age-matched healthy
children and from children with wasting or
stunting have revealed bacteria that are discriminatory for weight gain, including several bacteria
in the ecogroup taxa.5,10 In mice that were colonized with microbiota obtained from a wasted
or stunted child, supplementation with five of
1518
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these strains prevented microbiota-dependent
transmission of an impaired weight-gain phenotype.10 On the basis of these observations, and
through the screening of combinations of food
staples in gnotobiotic mice and gnotobiotic piglets, we developed several microbiota-directed
complementary food (MDCF) prototypes.8 We
compared three of these formulations with an
existing ready-to-use supplementary food (RUSF)
in a 1-month-long, randomized, controlled trial
involving children between the ages of 12 months
and 18 months with moderate acute malnutrition who were living in an urban slum known as
Mirpur, located in Dhaka, Bangladesh. One of
these formulations (MDCF-2) changed the microbiota to a composition similar to that of agedmatched healthy Mirpur children and changed
the levels of plasma proteins indicative of improved health status.5,8 Here, we report the results of a larger study conducted over a longer
period to compare the effects of MDCF-2 and
RUSF on clinical end points.

Me thods
Study Design

The study, which was conducted in Mirpur from
November 2018 through December 2019, was
approved by the ethics review committee at the
International Centre for Diarrhoeal Disease Research, Bangladesh. Parents or guardians of all
the study participants provided written informed
consent.
Boys and girls with moderate acute malnutrition who were between 12 months and 18 months
of age and who satisfied the inclusion and exclusion criteria were randomly assigned to receive
MDCF-2 or RUSF (Fig. 1A). The caloric density of
MDCF-2 is lower than that of RUSF (204 kcal vs.
247 kcal per 50-g daily dose). Anthropometric
features were measured every 15 days, and data
regarding health complications were documented daily. Field research assistants monitored the
children for any adverse events and treated them
according to standard of care, if needed.
During the first month, the children’s mothers fed them two daily 25-g servings of MDCF-2
or RUSF at a local study center under the supervision of a health care provider; the amount that
had not been consumed was determined by
weighing. In the second month, one of the two
daily feedings occurred at home, and the amount
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Figure 1. Study Design and Change in Weight-for-Length Measure Associated with MDCF-2 and RUSF Supplementation.
Panel A shows the study design for the evaluation of children between the ages of 12 months and 18 months with
moderate acute malnutrition who were treated with microbiota-directed complementary food (MDCF-2) or ready-touse supplementary food (RUSF). Panel B shows the change in the weight-for-length z score in the two groups during
the 3-month treatment period. The 0.011 value is the mean between-group difference in the rate of growth per week,
which was faster in the MDCF-2 group. The shaded areas around the curves indicate 95% confidence intervals.

consumed was documented; in the third month,
both daily feedings were provided at home.
Other than being asked to avoid feeding their
children during the 2-hour period before each
visit, mothers were advised to continue their
usual breast-feeding and complementary feeding
practices throughout the study. After completing
3 months of the intervention, the children returned to their normal feeding routine but continued to be monitored; fecal samples and anthropometric data were collected 1 month after
the discontinuation of treatment.
n engl j med 384;16

Details regarding the composition and nutritional analysis of the diets are provided in Table
S1 in Supplementary Appendix 2, which includes
all the cited supplementary tables. Additional
details regarding the study methods (including
the use of food-frequency questionnaires) and all
supplementary figures are included in Supplementary Appendix 1; details regarding the inclusion criteria and sample-size calculations are
provided in the protocol.11 All the supplementary
materials and the protocol are provided with the
full text of this article at NEJM.org.
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MDCF-2
(N = 61)

RUSF
(N = 62)

Age — mo

15.4±1.9

15.5±2.0

Female sex — no. (%)

35 (57)

36 (58)

Demographic

Anthropometric feature
Weight-for-length z score

−2.31±0.29

−2.40±0.27

Weight-for-age z score

−2.69±0.67

−2.76±0.62

Length-for-age z score

−2.08±1.16

−2.08±1.12

Mid–upper-arm circumference — cm

12.8±0.53

12.7±0.44

Breast-feeding status — no. (%)
No breast-feeding since birth

1 (2)

0

Partial breast-feeding

46 (75)

46 (74)

Exclusive breast-feeding

14 (23)

16 (26)

Immunization status — no. (%)
Complete

53 (87)

52 (84)

Partial

8 (13)

6 (10)

None

0

4 (6)
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regarding medical complications. Because we
tested the effects of the supplements on four
measures of growth and did not correct for multiple testing, we have provided confidence intervals for each outcome.
Changes in levels of plasma proteins were
analyzed with the use of an empirical Bayesian
linear model framework12 and gene-set enrichment analysis,13 a method for quantifying whether a rank-ordered list of features (e.g., proteins
that are ranked according to the changes in
levels after treatment or by a correlation coefficient) are enriched for a subgroup of features of
interest (e.g., a biologic pathway). We used linear
mixed-effects models and gene-set enrichment
analysis to quantify the effects of supplementation on microbial community configuration. For
all statistical analyses, a P value of less than 0.05
was considered to indicate statistical significance.
For analyses requiring adjustment for multiple
hypotheses, significance was indicated by a false
discovery rate–adjusted P value (Q value) of less
than 0.10 for the comparison in the plasma proteomic data set and of less than 0.05 for the
comparison in the fecal microbial data set. All
reported P and Q values are two-sided.

Table 1. Characteristics of the Children at Baseline.*
Characteristic

of

*	Plus–minus values are means ±SD. MDCF-2 denotes microbiota-directed
complementary food, and RUSF ready-to-use supplementary food.

End Points

Outcome measures were the weekly rate of
change in the weight-for-length z score, weightfor-age z score, mid–upper-arm circumference,
length-for-age z score, medical complications,
plasma proteomic profile, and gut microbiota
configuration.
Statistical Analysis

We compared changes in ponderal growth between the two groups using linear mixed-effects
models that included fixed effects to control for
differences in characteristics between the children at baseline (age, sex, and the occurrence of
illness 7 days before starting the intervention),
the number of weeks of the intervention, treatment group, the interaction between the number
of weeks of the intervention and the treatment
group, and a random-effects coefficient for each
child to account for the within-participant correlation; other anthropometric measures were assessed in a similar fashion. We used generalized
linear mixed-effects models to analyze responses
on the food-frequency questionnaire and data

1520
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R e sult s
Clinical Characteristics

Of the 123 children who underwent randomization, 61 were assigned to receive MDCF-2 and 62
to receive RUSF (Fig. S1 in Supplementary Appendix 1). The mean (±SD) age of the children was
15.4±2.0 months. A total of 59 children in each
group completed the 3-month intervention and
1-month follow-up. Five children did not complete the study because of family relocation or
withdrawal of consent.
At enrollment, the anthropometric and sociodemographic characteristics of the children
were similar in the two groups (Table 1, and
Table S3 in Supplementary Appendix 2). During
the 3-month intervention period, the mean (±SE)
percentage of the 50-g daily dose of supplement
that the children actually consumed was similar
in the MDCF-2 group and the RUSF group
(92.5±0.7% and 92.0±1.2%, respectively; P = 0.87).
There were no discernible between-group differences in the percentages of children who met
the World Health Organization requirements for
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Table 2. Clinical Response to MDCF-2 or RUSF Supplementation.*
MDCF-2
(N = 59)

RUSF
(N = 59)

Difference
(95% CI)†

Weight-for-length z score

−2.22±0.39

−2.29±0.36

0.086 (−0.056 to 0.228)

Anthropometric Feature
At baseline
Weight-for-age z score

−2.66±0.67

−2.71±0.64

0.036 (−0.213 to 0.285)

Length-for-age z score

−2.14±1.14

−2.13±1.13

−0.044 (−0.467 to 0.380)

MUAC — cm

12.8±0.51

12.7±0.44

0.077 (−0.100 to 0.254)

Weight-for-length z score

0.021 (0.014 to 0.029)

0.010 (0.003 to 0.017)

0.011 (0.001 to 0.021)

Weight-for-age z score

0.017 (0.012 to 0.022)

0.010 (0.004 to 0.015)

0.008 (0.001 to 0.015)

Length-for-age z score

0.004 (0.002 to 0.007)

0.005 (0.003 to 0.008)

−0.001 (−0.005 to 0.003)

MUAC — cm

0.031 (0.029 to 0.034)

0.029 (0.025 to 0.032)

0.003 (−0.001 to 0.007)

Mean rate of growth per week during
3-mo treatment (95% CI)‡

Mean rate of growth per week during
treatment plus 1-mo follow-up
(95% CI)‡
Weight-for-length z score

0.010 (0.005 to 0.016)

0.000 (−0.005 to 0.006)

0.010 (0.002 to 0.018)

Weight-for-age z score

0.009 (0.005 to 0.013)

0.001 (−0.003 to 0.005)

0.008 (0.002 to 0.013)

Length-for-age z score

0.004 (0.002 to 0.006)

0.003 (0.001 to 0.006)

0.000 (−0.003 to 0.003)

MUAC — cm

0.028 (0.026 to 0.031)

0.024 (0.022 to 0.027)

0.004 (0.000 to 0.007)

*	Plus–minus values are means ±SD. MUAC denotes mid–upper-arm circumference.
†	Values for the between-group difference at baseline were derived from a linear model predicting anthropometric features
at the start of treatment as a function of treatment group after adjustment for age, sex, and any illness within 7 days
before treatment initiation. Values for the between-group difference in the growth rate per week during the 3-month
treatment period and during treatment plus 1-month follow-up were derived from a mixed-effects linear model predicting anthropometric features as a function of the interaction between treatment group and the number of weeks since
the initiation of nutritional supplementation after adjustment for the baseline variables plus the number of weeks of
treatment, the treatment group, and a random intercept for each participant to account for the within-participant correlation. Positive values indicate a faster growth rate in children receiving MDCF-2.
‡	Values for the rate of growth per week during the treatment period and during treatment plus follow-up were derived
from a mixed-effects linear model. This model predicts anthropometric features as a function of the number of weeks
since the initiation of nutritional supplementation after adjustment for the baseline variables plus a random intercept
for each participant to account for the within-participant correlation.

minimum meal frequency or minimum acceptable diet. (Details regarding the children’s dietary
practices are provided in Table S4 and in Supplementary Appendix 1.)
Response to Nutritional Intervention

Findings after the 3-month intervention suggest
that children in the MDCF-2 group had better
outcomes than those in the RUSF group with
respect to the mean (±SD) change in two of the
four key anthropometric measurements that were
evaluated: weight-for-length and weight-for-age
z scores (Table 2). The mean weekly change in
the weight-for-length z score was 0.021 (95%
confidence interval [CI], 0.014 to 0.029) in the

n engl j med 384;16

MDCF-2 group and 0.010 (95% CI, 0.003 to 0.017)
in the RUSF group, for a between-group difference of 0.011 (95% CI, 0.001 to 0.021). The mean
weekly change in the weight-for-age z score was
0.017 (95% CI, 0.012 to 0.022) in the MDCF-2
group and 0.010 (95% CI, 0.004 to 0.015) in the
RUSF group, for a between-group difference of
0.008 (95% CI, 0.001 to 0.015). For the mid–
upper-arm circumference, the mean weekly
change was similar in the two groups, with an
increase of 0.031 cm (95% CI, 0.029 to 0.034) in
the MDCF-2 group and 0.029 cm (95% CI, 0.025
to 0.032) in the RUSF group, for a betweengroup difference of 0.003 cm (95% CI, −0.001
to 0.007). In the fourth category (length-for-age
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z score), the mean weekly change was 0.004
(95% CI, 0.002 to 0.007) in the MDCF-2 group
and 0.005 (0.003 to 0.008) in the RUSF group, for
a between-group difference of −0.001 (95% CI,
−0.005 to 0.003).
In these analyses, a greater positive value indicates a faster growth rate among the children
who received MDCF-2 than among those who
received RUSF. For example, an extrapolation of
the between-group difference of 0.011 per week
in the change from baseline in the weight-forlength z score would result in a gain of 0.57 over
that in the RUSF group at 1 year. The betweengroup difference in the change from baseline
during the 4-month period encompassing the
3-month intervention and the 1-month follow-up
was 0.010 (95% CI, 0.002 to 0.018) for the
weight-for-length z score, 0.008 (95% CI, 0.002
to 0.013) for the weight-for-age z score, 0.004 cm
(95% CI, 0.000 to 0.007) for the mid–upper-arm
circumference, and 0.000 (−0.003 to 0.003) for
the length-for-age z score (Table 2, Fig. 1B, and
Table S5). Details regarding the changes in medical complications and dietary habits are provided
in Figures S2 and S3 and in Tables S4 and S6.
Effects of Interventions on Plasma Proteome

We quantified the levels of 4977 proteins14 in
plasma samples collected from all 118 children in
the study at baseline, at 1 month, and at 3 months
(Fig. S4A and S4B and Table S2). For each child,
we constructed a linear model relating the duration of supplementation to the child’s weight-forlength z score during the 3-month intervention.
We then correlated this change with changes in
the levels of plasma proteins before and after
completion of the intervention (Fig. 2A, 2B, and
2C). A total of 75 proteins had a significant correlation (either positive or negative) with the
change in the weight-for-length z score (Q<0.10)
(Table S7).
Gene-set enrichment analysis querying Gene
Ontology biologic processes revealed that proteins that were positively correlated with the
change in the weight-for-length z score were
significantly enriched (Q<0.10) for mediators of
bone growth and ossification (e.g., insulin-like
growth factor 1), cartilage oligomeric matrix
protein (an extracellular matrix protein critical
for endochondral bone growth),15,16 and secreted
frizzled-related protein 4 (a Wnt inhibitor that

1522
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prevents excessive osteoclast erosion of bone)17
(Fig. 2D and 2E and Tables S7 and S8). The correlated proteins were also enriched for CNS development, including the axon guidance protein
SLIT and NTRK-like protein 5, BDNF/NT-3 growth
factor receptor (NTRK3), and roundabout homologue 2 (an axon guidance receptor with proosteoblastic and anti-osteoclastic activities)18
(Fig. 2F and Tables S7 and S8).
Proteins that had a negative correlation with
ponderal growth were significantly enriched for
acute phase reactants and actuators of immune
activation (e.g., hepcidin, which reduces iron
absorption and induces iron sequestration during inflammatory states), RANKL (osteoclastpromoting factor), granulysin (a proinflammatory
cytokine produced by activated cytotoxic T cells
and natural killer cells), interferon-induced protein with tetratricopeptide repeat-3 (which inhibits
the replication of multiple viral pathogens19), and
immunoglobulin A (Tables S7 and S8).
A total of 714 proteins had significantly
(Q<0.10) higher or lower levels after the 3-month
MDCF-2 supplementation, in contrast with 82
proteins that showed significant alterations after
RUSF treatment (Table S9A and S9B). Proteins that
showed increases after 3 months of supplementation with MDCF-2 were significantly enriched for
the set of 70 proteins that were positively correlated with the change in the weight-for-length
z score (P<0.001), in contrast with the proteins
that showed increases after RUSF supplementation (P = 0.11) (Fig. S5A and S5B). Comparing the
two treatments revealed that proteins with greater increases in the MDCF-2 group were significantly enriched for proteins associated with the
weight-for-length z score (P<0.001) (Fig. 2G). Of
these proteins that had increased levels after
MDCF-2 supplementation, cartilage intermediate
layer protein 2 was elevated to the greatest extent. Its levels did not change in children who
received RUSF. This protein forms complexes
with collagen VI to promote articular cartilage
formation and regulates metabolic status.20
Other proteins that had significant increases in
the MDCF-2 group but not in the RUSF group
included thrombospondin-4, a multifunctional
protein that is involved in the development of
bone, skeletal muscle, and vascular and nervous
systems,21 and the osteoclast inhibitor SFRP4.
We performed an analysis of the plasma pro-
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teomes among children in the MDCF-2 group
according to the quartile of ponderal growth
rate (change in the weight-for-length z score);
each quartile included 15 children. We found
that the children in the upper quartile of change
had started off more wasted, had lower levels of
mediators of bone growth and neurodevelopment, and had higher levels of proinflammatory
proteins than those in the lower quartile of
change. By the end of MDCF-2 supplementation,
children in the upper quartile had the largest
increases in mediators of bone growth and CNS
development and the largest decreases in effectors of inflammation (Fig. S6A and S6B and
Tables S10 and S11). Together, these results
provide evidence that mediators of bone growth,
neurodevelopment, and inflammation distinguished the effects of the MDCF-2 nutritional
intervention from that of RUSF.
Effects of Supplementation on Gut
Microbiota

To determine the effects of supplementation on
gut microbiota, we obtained fecal samples every
10 days during the first month of the intervention and monthly thereafter. Quantitative polymerase-chain-reaction (PCR) assays showed no
significant differences between treatments in the
representation of 23 bacterial, viral, and protozoan enteropathogens (Table S12). A more comprehensive analysis was obtained by identifying
bacterial taxa through sequencing of PCR amplicons generated from variable region 4 of 16S
ribosomal DNA (rDNA) genes present in fecal
biospecimens (Fig. S7). We then used linear
mixed-effects models to determine the relationships between the levels of bacterial taxa, which
were defined by the representation of amplicon
sequence variants (ASVs), and the weight-forlength z score for each participant.
An analysis of the ASV data that were generated from 706 fecal samples with temporally
matched anthropometric features showed that
among the 209 ASVs that satisfied a set threshold for prevalence and abundance, 23 were significantly associated with the weight-for-length
z score (called WLZ-associated taxa) in a linear
mixed-effects model. Of these taxa, 21 were
positively associated; the 2 taxa that were negatively associated were a bifidobacterium species
(probably B. longum, ASV_1) and Escherichia coli

n engl j med 384;16

(ASV_3) (Fig. 3A and Table S13). Six of the WLZassociated taxa are members of the ecogroup
network of bacteria that had been identified in a
previous study involving healthy Bangladeshi
infants and children who had normal development of their gut microbiota.5 In that study,
microbiota repair by MDCF-2 was accompanied
by changes in 2 of the 6 WLZ-associated ecogroup taxa: increases in Prevotella copri and reductions in B. longum.5 Five of the WLZ-associated
ASVs that were identified in the present study
share taxonomic similarity with bacteria identified as discriminatory for weight gain in our
previous studies of gnotobiotic mice colonized
with fecal microbiota from healthy versus malnourished children; they include Faecalibacterium
prausnitzii, Dorea formicigenerans, Ruminococcus gnavus
and a clostridium species. The complementary
food ingredients that were included in MDCF-2
were selected on the basis of their abilities to
increase the fitness and expressed beneficial
functions of these age- and growth-discriminatory taxa.8 An analysis of covariance between
features of the plasma proteome and members
of the gut microbiota revealed that the levels of
these 21 WLZ-associated taxa had correlation
with the 70 plasma proteins that were positively
associated with changes in the weight-for-length
z scores (Figs. S8, S9, and S10 and Tables S14
and S15). Details regarding the associations between bacterial taxa and dietary practices are
provided in the Results section of Supplementary Appendix 1 and in Table S16.
The levels of WLZ-associated taxa increased
significantly more in the gut microbiota of children in the MDCF-2 group than in those of
children in the RUSF group (P<0.001) (Fig. 3B).
Data regarding the association between the WLZassociated taxa and the magnitude of changes in
their relative levels during MDCF-2 treatment are
provided in Figure S11 and Table S17. The greatest increases occurred with P. copri and F. prausnitzii, whereas the bifidobacterium species had
the greatest decrease. In addition, we compared
data from children in the MDCF-2 group and the
RUSF group with data from children in Mirpur
who had consistently healthy growth phenotypes
(weight-for-length z score, ≥1) and normally developing microbiota. In this comparison, children
in the MDCF-2 group had a significantly higher
rate of change in levels of ASVs assigned to the
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Discussion

Figure 2 (facing page). Effects of Nutritional Intervention
on Plasma Proteins.
Shown are schematic representations of the individual
ponderal growth rates expressed as the weight-for-length
z score (WLZ) (Panel A), the corresponding changes in
protein levels before and after treatment (Panel B), and
the overall correlation between these two values for a
particular protein (Panel C). In Panels A, B, and C, sample graphs illustrate the calculations that were performed
for all the participants. One assay, which simultaneously quantified the levels of 4977 proteins, was performed
for each plasma sample. Gene-set enrichment analysis
(GSEA) was used to identify biologic processes in the
Gene Ontology database that were enriched for the proteins that had a significant correlation with the rate of
ponderal growth (Panel D). P values were adjusted for
the false discovery rate (FDR) (i.e., Q value) and were
transformed to a negative log10 scale, with Q<0.10 indicating significance (vertical gray line). Proteins in which
changes in levels were positively correlated with changes
in weight-for-length z scores were significantly enriched
(Q<0.10) for mediators of ossification (Panel E) and
for development of the central nervous system (CNS)
(Panel F). In these two panels, only proteins for which
the correlation with the change in the weight-for-length
z score reached an unadjusted P<0.01 are shown. Proteins are ordered according to the strength of the correlation and colored according to the P value, which was
transformed to a negative log10 scale so that decreasing
values indicate less statistical significance. Also shown
are the differential effects of MDCF-2 or RUSF supplementation on proteins associated with the weight-forlength z score (Panel G). Proteins are ordered according to the log 2 of the ratio of the treatment effect of
MDCF-2 as compared with RUSF after 3 months of supplementation. GSEA was used to calculate the enrichment of proteins that had higher levels in the MDCF-2
group than in the RUSF group (P<0.001) for the set of
70 proteins that had a significant positive correlation
(Q<0.10) with the change in the weight-for-length z score.

prevotella species (including P. copri), F. prausnitzii,
olsenella species, and bifidobacterium species —
taxa that were the most highly positively and negatively correlated with weight-for-length z scores.
In contrast, children in the RUSF group did not
have significant differences in the rate of change
in levels of any of the 23 WLZ-associated ASVs
(Fig. S12 and Tables S18 and S19). One month
after cessation of supplementation, levels of a
majority of MDCF-2–responsive, WLZ-associated
ASVs had begun to fall. Although weight-forlength z scores were decreasing in both groups
during this period, the between-group disparity
in this measurement had become even more
pronounced (Table 2 and Fig. S13).
n engl j med 384;16

We describe the results of a randomized, controlled feeding study that tested the effects of a
microbiota-directed complementary food (MDCF-2)
against an existing supplementary food (RUSF)
on four measures of growth in Bangladeshi children between the ages of 12 months and 18
months who had moderate acute malnutrition.
Even though MDCF-2 has a lower caloric density
than RUSF, the rates of changes in two of these
measures — weight-for-length and weight-for-age
z scores — support the hypothesis that MDCF-2
promotes growth. We observed larger changes
in plasma protein mediators of bone growth,
neurodevelopment, and inflammation and more
complete repair of the gut microbiota in children who received MDCF-2 than in those who
received RUSF.
We did not attempt to test the effects of
MDCF-2 and RUSF on body composition (changes in fat mass vs. lean mass). Chronic undernutrition in early life induces metabolic reprogramming that may enable a child to more efficiently
capture and store energy as fat during periods of
nutrient scarcity.22 Although this metabolic shift
is adaptive in the short term, it predisposes children to the development of diabetes, hypertension, and cardiovascular disease later in life.23
MDCF-2 elicits a concerted change in WLZ-associated proteins, a number of which are effectors
of bone growth and skeletal-muscle development.
Some of these proteins have also been implicated in metabolic disorders.24-30 However, augmenting the growth of bone and skeletal muscle may
promote a rebalancing of the rapid catch-up in
fat accretion that has been observed when undernourished children are given standard nutritional
interventions. Such augmentation may also promote a more appropriate lean-to-fat mass ratio,
which would simultaneously improve growth and
provide protection from later obesity.31,32
Studies conducted in children with moderate
acute malnutrition in Malawi and Ethiopia have
shown that increases in fat-free mass during the
first 2 years of life are associated with better
cognitive and motor development.33,34 Children
who received MDCF-2 had increased plasma levels
of proteins that are associated with axonal
growth and CNS development; however, future
studies are needed to determine whether changes in the circulating levels of these proteins re-

nejm.org

april 22, 2021

1525

The New England Journal of Medicine
Downloaded from nejm.org at Washington University in St. Louis Becker Library on January 6, 2022. For personal use only. No other uses without permission.
Copyright © 2021 Massachusetts Medical Society. All rights reserved.

5

10

15

Prevotella sp.

Clostridium sp.

ASV_377

ASV_236*

n engl j med 384;16

ASV Abundance

nejm.org

ASV_66

ASV_6

Prevotella copri
Bifidobacterium sp.
Escherichia coli

Prevotella copri

Blautia wexlerae

ASV_134

ASV_14
ASV_1*
ASV_3

Prevotella copri

Prevotella stercorea

ASV_82

Blautia obeum

Prevotella copri

−0.025

0.000

0.025

β1 (ASV)

0.050

0.075

Bifidobacterium sp.

Bifidobacterium adolescentis
ASV_9
ASV_1

Blautia wexlerae
ASV_6

Prevotella copri
Coprococcus/eubacterium sp.
ASV_45

ASV_82

−0.5

0

0.5

1.0

∆ASV (3-mo vs. baseline) MDCF-2−RUSF

−1.0

of

ASV_15

Clostridium sp.

ASV_37*

Prevotella copri
Clostridium sp.

ASV_37

Faecalibacterium prausnitzii

ASV_13*

ASV_15

Dorea formicigenerans

ASV_31*

Ruminococcus gnavus
Clostridium sp.

ASV_22

Coprococcus/eubacterium sp.

ASV_45
ASV_236

ASV_14

Mitsuokella multacida

Escherichia coli
Prevotella copri

Faecalibacterium prausnitzii

Olsenella sp.

ASV_3

ASV_41

ASV_125

n e w e ng l a n d j o u r na l

ASV_27

Prevotella copri
Prevotella stercorea

ASV_734 Lachnoclostridium/hungatella sp.

ASV_134

ASV_66

Bifidobacterium adolescentis

ASV_192

ASV_31
Mitsuokella multacida

Mitsuokella jajaludinii
Dorea formicigenerans

ASV_178

ASV_192

Blautia obeum

Faecalibacterium prausnitzii

Blautia sp.

Prevotella sp.

Assigned Taxonomy

ASV_27

ASV_13

ASV_21

ASV_377

ASV

B Between-Group Change in ASV Abundance

ASVs with significant negative associations with WLZ

ASV_9

Ruminococcus gnavus

ASV_22*

Blautia sp.

Olsenella sp.

Mitsuokella jajaludinii

ASV_178

Lachnoclostridium/hungatella sp.

ASV_734

ASV_125

Faecalibacterium prausnitzii

ASV_21

−1.0
−1.0−1.5
−1.0−1.5−2.0
−1.5−2.0−2.5
−2.0−2.5
5 10 15
−2.5
5 Weeks
10 15
0
Participant 3
5 Weeks
10 15
0
Participant 2
Weeks
Participant 1

Bacterial Abundance

WLZ ~β1 (ASV)+β2 (week in study)+(1PID)

Weeks
15
0
5 10
Participant 3
Weeks
5 10
15
Participant 2
Weeks
Participant 1

−1

Assigned Taxonomy

0

−

−1

0

1

0

ASV_41*

−2

−1

0

WLZ

ASV

WLZ

1

WLZ

1

Bacterial Abundance

1526

A Association between WLZ and Number of ASVs in Bacterial Taxa

ASVs with significant positive associations with WLZ

The

m e dic i n e

april 22, 2021

The New England Journal of Medicine
Downloaded from nejm.org at Washington University in St. Louis Becker Library on January 6, 2022. For personal use only. No other uses without permission.
Copyright © 2021 Massachusetts Medical Society. All rights reserved.

Microbiota Intervention for Undernourished Children

deshi children (and in those in other resourcepoor settings) is the transition from a community
dominated by B. longum during exclusive or predominant breast-feeding to one in which Prevotella copri becomes a major component during
weaning.5 Although B. longum has been associated
with numerous beneficial outcomes in breastfeeding infants, the level of this organism was
negatively associated with the ponderal growth
rate in the children enrolled in the present study,
which underscores the importance of considering how the timing of nutritional intervention
aligns with the state of microbiota development.
Larger trials will need to be performed in
disparate geographic regions to further assess
the efficacy of this therapeutic approach for
treating childhood undernutrition. The plasma
and microbiota biomarkers that were identified
in the present study should help enable better
characterization and stratification of participants
in future interventions.

Figure 3 (facing page). Response of the Gut Microbiota
to MDCF-2 and RUSF Supplementation.
Panel A shows linear mixed-effects modeling of the relationship between the weight-for-length z score and
the number of bacterial taxa (amplicon sequence variants [ASV]) in the two study groups. Each assay simultaneously quantified the abundance of 209 ASVs in each
fecal sample. The coefficient β1 represents the change
in the weight-for-length z score for a unit change in the
variance-stabilizing, transformed level of an ASV. A random effect (indicated by a vertical bar) for a participant
ID (PID) was included in the model to account for repeated measurements obtained from the same participant.
Bar graphs indicate β1 (the linear model coefficients)
±SE for each taxon that was significantly associated with
the weight-for-length z score. ASVs in boldface were previously identified as taxa belonging to a so-called ecogroup network consisting of 15 bacterial taxa that were
detected during the first 2 years of life in children with
normal development of the gut microbiota.5 Asterisks
indicate taxa that have previously been described as
having associations with weight gain in gnotobiotic mice
with gut microbial communities obtained from both
healthy and undernourished children.10 Panel B shows
the change in variance-stabilizing transformed ASV
counts (ΔASV) over the 3-month course of supplementation in the MDCF-2 group as compared with the RUSF
group. A positive value for the difference indicates a
greater average increase in a given taxon among the
children in the MDCF-2 group, whereas a negative value
indicates a greater average decrease. Gene-set enrichment analysis was used to quantify the number of taxa
associated with weight gain that increased more in the
MDCF-2 group than in the RUSF group (P<0.001).

flect changes in the brain itself. In addition, it
will be important to follow cohorts of children
with moderate acute malnutrition who have been
treated with MDCF-2 for longer periods to assess
whether the observed changes in these proteins
correlate with clinical improvements in cognitive performance.
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